Social acceptability of prenatal diagnosis : The example of Down syndrome;Acceptabilité sociale du diagnostic prénatal : L'exemple de la trisomie 21

Medecine/Sciences

Volumn 12, Issue 3, 1996, Pages 333-339

  Julian Reynier, Claire ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME ABERRATION; DOWN SYNDROME; FRANCE; HIGH RISK POPULATION; HUMAN; HUMAN RIGHTS; INDUSTRIALIZATION; INFORMED CONSENT; MATERNAL AGE; MENTAL DEFICIENCY; PRENATAL DIAGNOSIS; PREVALENCE; REVIEW; RISK FACTOR; SOCIAL ASPECT; TRISOMY 21;

EID: 0029914695     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/736     Document Type: Article

References (49)

1. Boué A. Cytogenetic of pregnancy wastage. In: Harris HK, ed. Advances in Human genetics. New York: Plenum Publishing Corp, 1985; 14: 1-50.
2. Penrose LS. The relative effect of paternal age and maternal age on mongolism. J Genet 1933; 27: 219-44.
3. Reid M. The diffusion of four prenatal screening tests across EEC countries. London: KFC. eds, 1991.
4. Cook RJ, Dickens BM. International developments in abortion laws: 1977-88. Am J Publ Health 1988; 78: 1305-11.
5. Powledge TM, Fletcher J. Guidelines for the ethical, social and legal issues in prenatal diagnosis. N Engl J Med 1979; 300: 168-72.
6. Wertz D, Fletcher JC, Mulvihill JJ. Medical geneticists confront ethical dilemmas: cross-cultural comparisons among 18 nations. Am J Hum Genet 1990; 46: 1200-13.
7. Arrow KJ. Uncertainty and the welfare economics of medical care. Am Economic Rev 1963; 53: 941-73.
8. Lippman-Hand A, Cohen DI. Influence of obstetricians' attitudes on their use of prenatal diagnosis for the detection of Down's syndrorne. Can Med Assoc J 1980; 122: 1381-4.
9. Renaud M, Bouchard L, Kremp O, et al. Is selective abortion for a genetic disease an issue for the medical profession? A comparative study of Quebec and France. Prenat Diagn 1993; 13: 691-706.
10. Julian C, Aymé S, Huard P, et al. Physician's acceptability of termination of pregnancy after prenatal diagnosis. Prenat Diagn 1989; 9: 77-89.
11. Hofman KJ, Tambor ES, Chase GA, et al. Physicians' knowledge of genetics and genetic tests. Acad Med 1993; 68: 625-32.
12. Julian C, Aymé S, Huard P, et al. Diffusion du conseil génétique et du diagnostic prénatal: l'impact des connaissances des médecins. Rev Epidemiol Sante Publ 1986; 34: 365-72.
13. Geller G, Tambor ES, Papiernik E. Attitudes toward abortion for fetal anomaly in the second versus the third trimester: a survey of parisian obstetricians. Prenat Diagn 1993; 13: 707-22.
14. Zare N, Sorenson JR, Heeren T. Sex of provider as a variable in effective genetic counselling. Soc Sci Med 1984; 19: 671-5.
15. Clarke A. Non directive genetic counselling. Lancet 1991; 338: 1524.
16. Julian-Reynier C, Macquart-Moulin G, Moatti J, et al. Reasons for women's non uptake of amniocentesis. Prenat Diagn 1994; 14: 859-64.
17. Marteau TM, Drake H. Attributions for disability: the influence of genetic screening. Soc Sci Med 1995; 40: 1127-32.
18. Renaud MBL, Kremp O. Diagnostic prénatal et choix de société: le non-dit du développement technologique. In: Moatti JP, ed. Évaluation des innovations technologies et décisions en Santé Publique. Paris: Inserm-La Documentation Française, 1992: 203-20.
19. Brandenburg H, Groenhuijzen J, Jahoda MG J, et al. Reproductive behaviour following spontaneous loss of a pregnancy after prenatal diagnosis. Clin Genet 1992; 42: 149-51.
20. Julian-Reynier C, Macquart-Moulin G, Moatti J, et al. Attitudes of women of child-bearing age towards prenatal diagnosis in southeastern France. Prenat Diagn 1993; 13: 613-27.
21. Bourret P. Le temps, l'espace en génétique. Intervention médicale et géographie sociale du gène. Sci Soc Santé 1988; 6: 171-98.
22. Lippman-Hand A, Kipper M. Prenatal diagnosis for the detection of down syndrome: why are so few eligible women tested? Prenat Diagn 1981; 1: 249-57.
23. Mikkelsen M, Fischer G, Hansen J, et al. The impact of legal termination of pregnancy and of prenatal diagnosis on the birth prevalence of Down syndrome in Denmark. Ann Hum Genet 1983; 47: 123-31.
24. Gardent H, Goujard J, Fardeau M, et al. Analyse économique de la diffusion d'une innovation médicale: l'exemple du diagnostic prénatal par amniocentèse précoce. Rev Epidemiol Sante Publ 1984; 32: 88-96.
25. Briard ML. Évaluation des innovations technologiques et décisions en Santé Publique. Collection Analyse et Prospective. In: Moatti JP, Mawas C, eds. Paris: Éditions Inserm, 1992: 171-86.
26. Bell J, Pearn JH, Brownjea A, et al. Utilization of prenatal diagnostic in women of advanced maternal age in Australia. Prenat Diagn 1985; 5: 53-8.
27. Baird PA, Sadovnick AD, McGillivray BC. Temporal changes in the utilization of amniocentesis for prenatal diagnosis by women of advanved maternal age, 1976-1983. Prenat Diagn 1985; 5: 191-8.
28. Moatti JP, Le Galès C, Julian C, et al. Socio-cultural inequities in access to prenatal diagnosis: the role of insurance coverage and regulatory policies. Prenat Diagn 1990; 10: 313-25.
29. Halliday J, Lumley J, Watson L. Comparison of women who do and do not have amniocentesis or chorionic villus sampling. Lancet 1995; 345: 704-9.
30. Seals BF, Ekwo EE, Williamson RA, et al. Moral and religious influences on the amniocentesis decision. Soc Biol 1985; 32: 13-30.
31. Brégeault A, Aurran Y, Julian-Reynier C. Knowledge of prenatal diagnosis and acceptability of termination of pregnancy among immigrant women living in France. Med Genet 1994; 3: 352.
32. Doherty RA, Roghmann KJ. Knowledge, attitudes, and acceptance of prenatal diagnosis among women and physicians in the Rochester region. Service Edu Med Genet 1979; 323-34.
33. Lippman-Hand A, Fraser FC. Genetic counselling: parents' responses to uncertainty. Birth Defect 1979; 15: 325-39.
34. Edwards AWF. Probability and likelihood in genetic counselling. Clin Genet 1989; 36: 209-16.
35. Kong A, Barnett GO, Mosteller F. How medical professionals evaluate expressions of probability. N Engl J Med 1986; 315: 740-4.
36. Weinstein ND. Why it won't happen to me: perceptions of risk factors and susceptibility. Health Psy 1984; 3: 431-57.
37. Bundey S. Attitudes of 40-year-old college graduates towards amniocentesis. Br Med J 1978; 2: 1475-7.
38. Wald NJ, Kennard A, Densem JW, et al. Antenatal maternal serum screening for down's syndrome: results of a demonstration project. Br Med J 1992; 305: 391-4.
39. Elkins TE, Stovall TG, Wilroy S, et al. Attitudes of mothers of children with Down syndrome concerning amniocentesis, abortion, and prenatal genetic counselling techniques. Obstet Gynecol 1986; 68: 181-4.
40. Swerts A. Impact of genetic counseling and prenatal diagnosis for Down syndrome and neural tube defects. In: Evers-Kiebooms G, et al., eds. Genetic risk, risk perception, and decision making. Birth defects Original articles series, vol. 23. New York: March of dimes birth defects foundation, Liss, 1987; 61-83.
41. Cornel MC, Breed ASPM, Beekhuis JR, et al. Down syndrome: effects of demographic factors and prenatal diagnosis on the future livebirth prevalence. Hum Genet 1993; 92: 163-8.
42. Gates EA. The impact of prenatal generic testing on quality of life in women. Fetal Diagn Ther 1993; 8 (suppl I): 236-43.
43. Kaplan D. Prenatal diagnosis and its impact on persons with disabilities. Fetal Diagn Ther 1993; 8 (suppl 1): 64-9.
44. Bensoussan P. L'annonce faite aux parents. Le nourrisson porteur d'une pathologie chronique, d'une malformation congénitale ou d'un handicap à la naissance. Neuropsy Enfance 1989; 37: 429-40.
45. Dumaret AC, Rosset DJ. Trisomie 21 et abandon. Arch Fr Pediatr 1993; 50: 851-7.
46. Julian-Reynier CAY, Dumaret A, Maron A, Chabal F, Giraud F, Aymé S. Attitudes towards Down's syndrome: follow up of a cohort of 280 cases. J Med Genet 1995; 32: 597-9.
47. Weitz R. Barriers to acceptance of genetic counselling among primary care physicians. Soc Biol 1979; 26: 189-97.
48. Lippman A. Research studies in applied human genetics: a quantitative analysis and critical review of recent literature. Am J Med Genet 1991; 41: 105-11.
49. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for down's syndrome with use of maternal serum markers. N Engl J Med 1992; 327: 588-93.